A5054431032- Advanced Radiotherapy Techniques
- Colorectal Cancer Surgical Treatments
- Prostate Cancer Treatment and Research
- Prostate Cancer Diagnosis and Treatment
- Colorectal and Anal Carcinomas
- Radiomics and Machine Learning in Medical Imaging
- Medical Imaging Techniques and Applications
- Gastric Cancer Management and Outcomes
- Esophageal Cancer Research and Treatment
- Colorectal Cancer Treatments and Studies
- Lung Cancer Diagnosis and Treatment
- Radiation Therapy and Dosimetry
- Cancer, Hypoxia, and Metabolism
- Advances in Oncology and Radiotherapy
- Colorectal Cancer Screening and Detection
- Radiopharmaceutical Chemistry and Applications
- Health Systems, Economic Evaluations, Quality of Life
- MRI in cancer diagnosis
- Pancreatic and Hepatic Oncology Research
- Cancer Genomics and Diagnostics
- Advanced X-ray and CT Imaging
- Radiation Dose and Imaging
- Hepatocellular Carcinoma Treatment and Prognosis
- Clinical practice guidelines implementation
- Effects of Radiation Exposure
KU Leuven
2016-2025
Universitair Ziekenhuis Leuven
2013-2024
Monash Medical Centre
2024
Sunshine Coast University Hospital
2024
The University of Melbourne
2024
Peter MacCallum Cancer Centre
2024
Monash University
2024
Franco-British Council
2023
Capital Region of Denmark
2023
Heidelberg University
2022
PURPOSE: A prospective study of preoperative tumor-node-metastasis staging patients with esophageal cancer (EC) was designed to compare the accuracy 18-F-fluoro-deoxy-d-glucose (FDG) positron emission tomography (PET) conventional noninvasive modalities. PATIENTS AND METHODS: Seventy-four carcinomas esophagus (n = 43) or gastroesophageal junction 31) were studied. All underwent attenuation-corrected FDG-PET imaging, a spiral computed (CT) scan, and an endoscopic ultrasound (EUS). RESULTS:...
This study investigates whether focal boosting of the macroscopic visible tumor with external beam radiotherapy increases biochemical disease-free survival (bDFS) in patients localized prostate cancer.In phase III, multicenter, randomized controlled Focal Lesion Ablative Microboost Prostate Cancer trial, 571 intermediate- and high-risk cancer were enrolled between 2009 2015. Patients assigned to standard treatment received 77 Gy (fractions 2.2 Gy) entire prostate. The boost arm an additional...
In 10–24% of patients with rectal cancer who are treated neoadjuvant chemoradiation, no residual tumor is found after surgery (ypT0). When accurately selected, these complete responders might be considered for less invasive treatments instead standard surgery. So far, imaging method has proven reliable. This study was designed to assess the accuracy diffusion-weighted MRI (DWI) in addition selection chemoradiation. A total 120 locally advanced from three university hospitals underwent...
The role of adjuvant chemoradiotherapy (CRT) in resectable pancreatic cancer is still debated. This randomized phase II intergroup study explores the feasibility and tolerability a gemcitabine-based CRT regimen after R0 resection head cancer.Within 8 weeks surgery, patients were randomly assigned to receive either four cycles gemcitabine (control arm) or for two followed by weekly with concurrent radiation (50.4 Gy; arm). primary objective was exclude < 60% treatment completion > 40% rate...
In Western countries, the current standard of care for resectable gastric cancer is perioperative chemotherapy. Preoperative chemoradiotherapy has been considered, but data are limited regarding this treatment as compared with chemotherapy alone.